Clinical Trial of SL1904B CAR-T Cells for Relapsed or Refractory Non-Hodgkin Lymphoma

Clinical trial NCT04447547 · UNKNOWN

Trial details

NCT number: NCT04447547
Sponsor: Hebei Senlang Biotechnology Inc., Ltd.
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Non-hodgkin's Lymphoma

Start date: 2020-06-30
Primary completion: 2022-08-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.